Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A26989 | 19396962 | Curr Opin Gastroenterol | Recent advances in nonalcoholic fatty liver disease. | 2009 | Details |
| A26994 | 19378390 | J Gastroenterol Hepatol | The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease. | 2009 | Details |
| A26996 | 19373421 | Can J Gastroenterol | Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis. | 2009 | Details |
| A27000 | 19370776 | World J Gastroenterol | Olive oil consumption and non-alcoholic fatty liver disease. | 2009 | Details |
| A27006 | 19362523 | Dig Liver Dis | Elevated serum ALT in children presenting to the emergency unit: Relationship with NAFLD. | 2009 | Details |
| A27010 | 19359436 | Gut | Toll-like receptors as targets in chronic liver diseases. | 2009 | Details |
| A27013 | 19355912 | Curr Mol Med | Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. | 2009 | Details |
| A27014 | 19353360 | Ann Med | New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD). | 2009 | Details |
| A27015 | 19352614 | J Mol Med (Berl) | Molecular mechanisms involved in NAFLD progression. | 2009 | Details |
| A27023 | 21495339 | Rev Med Chir Soc Med Nat Iasi | [Adipocytokines and nonalcoholic steatohepatitis]. | 2011 | Details |
| A27024 | 19330863 | Hepatology | Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease. | 2009 | Details |
| A27030 | 19317274 | Acta Gastroenterol Belg | Serum adiponectin levels in different types of non alcoholic liver disease. Correlation with steatosis, necroinflammation and fibrosis. | 2009 | Details |
| A27032 | 19302184 | Liver Int | Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease. | 2009 | Details |
| A27046 | 19280268 | Obes Surg | Expression of cytokine signaling genes in morbidly obese patients with non-alcoholic steatohepatitis and hepatic fibrosis. | 2009 | Details |
| A27050 | 19268270 | Clin Gastroenterol Hepatol | Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease. | 2009 | Details |
| A27053 | 19261002 | Hepatol Res | Role of hepatic iron in non-alcoholic steatohepatitis. | 2009 | Details |
| A27060 | 19243311 | Clin Sci (Lond) | Metabolic disturbances in non-alcoholic fatty liver disease. | 2009 | Details |
| A27061 | 19242728 | Pediatr Nephrol | Albuminuria and insulin resistance in children with biopsy proven non-alcoholic fatty liver disease. | 2009 | Details |
| A27062 | 19240815 | Hippokratia | Non alcoholic fatty liver disease and metabolic syndrome. | 2009 | Details |
| A27064 | 19231010 | J Hepatol | Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH. | 2009 | Details |
| A27077 | 19221529 | Ann Hepatol | Chemical shift magnetic resonance imaging is helpful in detecting hepatic steatosis but not fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). | 2009 | Details |
| A27078 | 19221528 | Ann Hepatol | Hepatogenous diabetes. Current views of an ancient problem. | 2009 | Details |
| A27082 | 19215335 | J Gastroenterol Hepatol | An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome. | 2009 | Details |
| A27083 | 19214773 | J Inherit Metab Dis | Combined hyperlipidaemia as a presenting sign of cholesteryl ester storage disease. | 2009 | Details |
| A27090 | 19195629 | Diabetes Metab | Non-invasive diagnosis of steatosis and fibrosis. | 2008 | Details |
| A27094 | 19195624 | Diabetes Metab | Definition and natural history of metabolic steatosis: histology and cellular aspects. | 2008 | Details |
| A27095 | 19195623 | Diabetes Metab | Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis. | 2008 | Details |
| A27096 | 19194305 | Eur J Gastroenterol Hepatol | Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients. | 2009 | Details |
| A27107 | 19162235 | Clin Gastroenterol Hepatol | Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease. | 2008 | Details |
| A27111 | 19155426 | J Am Coll Nutr | Nonalcoholic fatty liver disease in children. | 2008 | Details |
| A27116 | 19142989 | Hepatology | Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network. | 2009 | Details |
| A27118 | 19140676 | J Proteome Res | Serum protein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steatohepatitis. | 2009 | Details |
| A27119 | 19140227 | World J Gastroenterol | Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. | 2009 | Details |
| A27126 | 19119140 | J Biol Chem | Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase. | 2009 | Details |
| A27127 | 19118644 | Clin Gastroenterol Hepatol | Noninvasive assessment of hepatic steatosis. | 2008 | Details |
| A27131 | 21179914 | Rom J Intern Med | Liver biopsy versus noninvasive methods--fibroscan and fibrotest in the diagnosis of non-alcoholic fatty liver disease: a review of the literature. | 2009 | Details |
| A27134 | 20469674 | Eksp Klin Gastroenterol | [Non-alcoholic fatty liver disease: age peculiarities, breakthrough in pathogenetic therapy]. | 2009 | Details |
| A27137 | 19115316 | Hepatology | VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice. | 2009 | Details |
| A27142 | 19098851 | Am J Gastroenterol | The histologic spectrum of liver disease in African-American, non-Hispanic white, and Hispanic obesity surgery patients. | 2009 | Details |
| A27148 | 19084941 | World J Gastroenterol | Inhibition of hepatic interleukin-18 production by rosiglitazone in a rat model of nonalcoholic fatty liver disease. | 2008 | Details |
| A27155 | 19072834 | Hepatology | Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist. | 2009 | Details |
| A27156 | 19072371 | Expert Rev Gastroenterol Hepatol | Nonalcoholic fatty liver disease: from clinical recognition to treatment. | 2008 | Details |
| A27157 | 19072356 | Expert Rev Gastroenterol Hepatol | Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C. | 2008 | Details |
| A27160 | 18973845 | Gastroenterol Clin Biol | FibroMeters: a family of blood tests for liver fibrosis. | 2008 | Details |
| A27161 | 18973844 | Gastroenterol Clin Biol | FibroTest-ActiTest as a non-invasive marker of liver fibrosis. | 2008 | Details |
| A27163 | 19065650 | Hepatology | Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. | 2009 | Details |
| A27166 | 19055132 | Ned Tijdschr Geneeskd | [Liver cirrhosis in diabetes mellitus; a complication not always recognized]. | 2008 | Details |
| A27170 | 19052646 | PLoS One | Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers. | 2008 | Details |
| A27173 | 19038040 | J Transl Med | Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign? | 2008 | Details |
| A27174 | 19035982 | Aliment Pharmacol Ther | Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels. | 2008 | Details |
| A27177 | 19034237 | Ann Hepatol | Nonalcoholic fatty liver disease in severely obese individuals: the influence of bariatric surgery. | 2009 | Details |
| A27178 | 19034235 | Ann Hepatol | AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis. | 2009 | Details |
| A27180 | 19032450 | J Gastroenterol Hepatol | Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C. | 2008 | Details |
| A27187 | 19016382 | Scand J Gastroenterol | Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease. | 2009 | Details |
| A27191 | 19014569 | BMC Gastroenterol | Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH). | 2008 | Details |
| A27193 | 19013463 | Gastroenterology | Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis. | 2008 | Details |
| A27196 | 19005759 | Dig Dis Sci | Influence of visfatin on histopathological changes of non-alcoholic fatty liver disease. | 2008 | Details |
| A27197 | 19004189 | Adv Clin Chem | Biomarkers of liver fibrosis. | 2008 | Details |
| A27201 | 18995215 | Clin Gastroenterol Hepatol | Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients. | 2008 | Details |
| A27202 | 18992746 | Gastroenterology | Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease. | 2008 | Details |
| A27204 | 18989777 | Dig Dis Sci | Diagnostic value of serum prolidase enzyme activity to predict the liver histological lesions in non-alcoholic fatty liver disease: a surrogate marker to distinguish steatohepatitis from simple steatosis. | 2008 | Details |
| A27206 | 18986848 | Clin Gastroenterol Hepatol | Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. | 2008 | Details |
| A27208 | 18984463 | Clin Liver Dis | The global impact of hepatic fibrosis and end-stage liver disease. | 2008 | Details |
| A27211 | 18977552 | J Hepatol | Comparison of blood tests for liver fibrosis specific or not to NAFLD. | 2008 | Details |
| A27212 | 18976012 | Arch Pathol Lab Med | Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis? | 2008 | Details |
| A27214 | 18972077 | Adv Ther | Angiotensin receptor blockers in the treatment of NASH/NAFLD: could they be a first-class option? | 2008 | Details |
| A27217 | 18956297 | Semin Liver Dis | Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. | 2008 | Details |
| A27218 | 18956296 | Semin Liver Dis | Current and emerging therapies in nonalcoholic fatty liver disease. | 2008 | Details |
| A27219 | 18956295 | Semin Liver Dis | Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. | 2008 | Details |
| A27221 | 18956293 | Semin Liver Dis | Mechanisms of disease progression in nonalcoholic fatty liver disease. | 2008 | Details |
| A27222 | 18956292 | Semin Liver Dis | Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. | 2008 | Details |
| A27231 | 18942340 | Pol Merkur Lekarski | [Non invasive markers of non-alcoholic steatohepatitis]. | 2008 | Details |
| A27237 | 18929425 | J Hepatol | A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma. | 2008 | Details |
| A27238 | 18926950 | J Formos Med Assoc | Disease progression in a patient with nonalcoholic steatohepatitis. | 2008 | Details |
| A27241 | 18922966 | Pharmacol Rev | Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis. | 2008 | Details |
| A27254 | 18825466 | J Gastrointest Surg | Routine liver biopsy to screen for nonalcoholic fatty liver disease (NAFLD) during cholecystectomy for gallstone disease: is it justified? | 2008 | Details |
| A27257 | 26193649 | Clin J Gastroenterol | Development from simple steatosis to liver cirrhosis and hepatocellular carcinoma: a 27-year follow-up case. | 2008 | Details |
| A27263 | 18807134 | J Gastroenterol | Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases. | 2008 | Details |
| A27265 | 18804555 | Contemp Clin Trials | Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design. | 2008 | Details |
| A27267 | 18795706 | Hepatogastroenterology | Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk. | 2009 | Details |
| A27280 | 18762907 | Diabetologia | Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? | 2008 | Details |
| A27283 | 18753987 | Ann Hepatol | Imaging techniques for assessing hepatic fat content in nonalcoholic fatty liver disease. | 2009 | Details |
| A27287 | 18752331 | Hepatology | Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. | 2008 | Details |
| A27290 | 18721166 | Pediatr Diabetes | Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents. | 2008 | Details |
| A27294 | 18713296 | J Gastroenterol Hepatol | Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease. | 2008 | Details |
| A27296 | 18710430 | Liver Int | Hepatitis C virus infection enhances insulin resistance induced by visceral fat accumulation. | 2008 | Details |
| A27298 | 18702346 | Pol Merkur Lekarski | [Non-alcoholic fatty liver disease--new view]. | 2008 | Details |
| A27314 | 18662168 | Clin Sci (Lond) | Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. | 2008 | Details |
| A27315 | 18661429 | Scand J Gastroenterol | Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications. | 2009 | Details |
| A27319 | 18652898 | Pharmacol Res | Defining therapeutic targets for liver fibrosis: exploiting the biology of inflammation and repair. | 2008 | Details |
| A27320 | 18648737 | J Gastroenterol | Liver diseases and metabolic syndrome. | 2008 | Details |
| A27322 | 18647236 | Liver Int | Apnoeic-hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis. | 2008 | Details |
| A27323 | 18647235 | Liver Int | Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics. | 2008 | Details |
| A27326 | 18640473 | Clin Ther | Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study. | 2008 | Details |
| A27329 | 18637146 | Hepatol Res | Nonalcoholic steatohepatitis and hepatocellular carcinoma in galectin-3 knockout mice. | 2008 | Details |
| A27331 | 18636654 | World J Gastroenterol | Hepatic steatosis: a benign disease or a silent killer. | 2008 | Details |
| A27333 | 18627003 | Hepatology | Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. | 2008 | Details |
| A27340 | 18616651 | Am J Gastroenterol | Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis. | 2008 | Details |
| A27345 | 18609175 | Scand J Gastroenterol | Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity. | 2008 | Details |
| A27346 | 18609067 | Scand J Clin Lab Invest | Evaluation of blood oxidative stress-related parameters in alcoholic liver disease and non-alcoholic fatty liver disease. | 2008 | Details |